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SETTING:  Tanzania, with an estimated tuberculosis (TB) prevalence of 295 per 100,000 adult 27 
population. Currently, there is no nationally representative information on factors associated with 28 
TB in Tanzania.  29 
OBJECTIVE: To determine the demographic and clinical factors associated with 30 
bacteriologically-confirmed TB among adult general population of Tanzania.  31 
DESIGN: A case-control study nested in a nationally representative TB prevalence survey: All 32 
patients with bacteriologically-confirmed pulmonary TB constituted ‘cases’ and a representative 33 
sample of people without bacteriologically-confirmed pulmonary TB constituted ‘controls’. We 34 
calculated adjusted odds ratios (aORs) to identify factors associated with TB. 35 
RESULTS: Age groups [25-34 years (aOR 3.7; 95%CI 1.5-8.8), 55-64 years (aOR 2.5, 95%CI 36 
1.1-5.5)], male gender (aOR 1.6, 95%CI 1.1-2.3) and low body mass index (BMI) (aOR 1.7, 37 
95%CI 1.1-2.8) were significantly associated with TB. Association with HIV and diabetes were 38 
not statistically significant. Population attributable fraction (PAF) was 2% (95%CI-2 to 5%) for 39 
diabetes and 3% (95%CI -2% to 8%) for HIV.  40 
CONCLUSION: Being from older age groups, being male, and having low BMI were associated 41 
with bacteriologically-confirmed pulmonary TB. On a population level, classic risk factors for 42 
TB have no major effect on prevalent TB from which future transmission can derive.  43 
 44 
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Tuberculosis (TB) is unequally distributed in the world, with the highest incidence rates found in 48 
developing countries. In 2012, World Health Organization (WHO) ranked the TB burden in 49 
Tanzania 16th in the world.1  50 
 51 
A nationwide TB prevalence survey was conducted in 2011-2012 to establish a reliable estimate 52 
of the disease burden, as the WHO estimates were calculated using routine data with areas of 53 
uncertainty. The prevalence of bacteriologically confirmed pulmonary TB was 295/100,000 adult 54 
population. The survey estimated the case detection rate for smear-positive TB in 2012 to be 55 
between 42% and 54%.2 This indicates that the National TB and Leprosy Programme (NTLP) 56 
misses a large proportion of TB cases in the community, a source of continued transmission of 57 
disease. 58 
 59 
To cut the chain of transmission and end the tuberculosis epidemic, cases must be detected 60 
early.1 In the ‘End TB Strategy’ WHO recommends early detection of tuberculosis by systematic 61 
screening in selected high-risk groups to reach missing cases.3 Some examples of such high-risk 62 
groups include people who are in contact with TB cases, having previously been treated for TB, 63 
under-nourished, smokers, alcohol users, diabetes mellitus and HIV-infected patients.4 WHO 64 
acknowledged that no global strategy can apply similarly to all settings across or within 65 
countries, and that a sound knowledge of country-specific disease epidemiology is essential, 66 
including mapping of factors associated with TB.4 67 
  68 
To our knowledge, no national-level data on the factors associated with TB have been published 69 
from Tanzania. Some previous studies exist, but limited to district or regional level, small sample 70 
size, precluding nationally representative information.5, 6 The national TB prevalence survey 71 
provided a unique opportunity to assess factors associated with TB at national level with cases 72 
and controls sampled from the general population. This information will be useful for the NTLP 73 
in Tanzania as they begin to adapt the global End TB strategy. Thus, in this study, we aimed to 74 
determine the demographic and clinical factors associated with TB among adult general 75 
population of Tanzania.  76 





Study design and population 80 
This was a case-control study nested in a TB prevalence survey conducted among the adult 81 
population of Tanzania. The methodology of the prevalence survey has been described 82 
elsewhere.2 The survey population included individuals aged 15 years and above who slept in the 83 
selected households for at least the two weeks preceding the day of survey. 84 
 Cases: All bacteriologically confirmed pulmonary tuberculosis patients (any person with 85 
a positive sputum culture for Mycobacterium tuberculosis, OR at least two smear-positive 86 
for acid-fast bacilli, OR one smear-positive for acid-fast bacilli plus evidence of TB on 87 
diagnostic chest X-ray) identified in the prevalence survey. 88 
 Controls: All study participants who were tested and found not to have bacteriologically 89 
confirmed pulmonary TB and not receiving TB treatment: i.e. all presumptive TB 90 
patients without TB and a random sample of individuals without presumptive TB. 91 
 92 
Data collection 93 
Consenting participants were screened for TB by a symptom-questionnaire and a chest X-ray 94 
(CXR). Individuals with symptoms or CXR findings suggestive of TB were identified as 95 
‘presumptive TB’ and were requested to submit three sputum specimens and interviewed using a 96 
structured questionnaire for information regarding demographics and factors associated with TB. 97 
Two specimens were assessed by microscopy in a field laboratory; the third was transported to 98 
the Central Tuberculosis Reference Laboratory (CTRL) for culture in Lowenstein Jensen 99 
medium.  100 
Of the participants without presumptive TB, we randomly selected ten per cluster to serve as 101 
additional controls (additional to all those with presumptive TB but without bacteriologically 102 
confirmed TB). This ensured a study population in which controls were derived from the general 103 
population that consist of participants with or without presumptive TB. Every tenth survey 104 
participant who was not identified as having presumptive TB was requested to participate. If one 105 
refused, we requested the next eligible person and continued until we enrolled at least ten 106 
individuals in each cluster. The reason to include ten controls is rather pragmatic. First, this 107 
number would be logistically feasible for the study teams. Second, with this number we could 108 
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simply spread the controls over the total number of days that participants could be enrolled in the 109 
study. To avoid clustering, individuals were enrolled on three days (four people on day one and 110 
two, and two people on day three). These individuals also underwent all the procedures offered 111 
to those with presumptive TB as outlined above. As a result of this sampling strategy, we have 112 
taken a sample of the survey participants to be given a clinical work-up, and from this sample we 113 
have taken all cases and all non-cases. Doing so does not introduce bias leading to spurious 114 
associations in the study sample that are not present in the general population because this 115 
selection of participants for a clinical work-up was independent of exposure variables and the 116 
outcome. Using appropriate survey weights makes the results of the analysis representative for 117 
the general population. 118 
 119 
Our prevalence survey aiming at a relative precision of 25% was powered on a point prevalence 120 
of smear-positive TB in the general population of 145/100000, which translates into a point 121 
prevalence of 260/100000 in the adult population. With a sample size of around 50000, we 122 
expected a number of smear-positive TB cases of 130.  123 
 124 
The exploratory variables included age, sex, height, weight, socio-economic position, marital 125 
status, education, smoking (never/ever), alcohol use (never/ever), previous history of TB, 126 
diabetes mellitus (self-reported), HIV status. Information on the socio-economic position of the 127 
participants was collected through an assets-score at the household level. We used a principal 128 
component analysis to compute an asset score for each individual and grouped all the study 129 
participants into three categories – low, medium and high socio-economic position – using 130 
cutoffs based on tertiles.7 HIV testing was done following national guidelines. In the initial 131 
clusters the sequence of rapid tests was SD Bioline, followed by Determine. The diagnosis was 132 
made if both tests were positive; if still indeterminate, the final diagnosis was made by Unigold. 133 
During the survey, the national guideline changed. Accordingly, the diagnosis of HIV in the 134 
survey was made by the successive use of Determine and Unigold. Again, HIV was diagnosed 135 






Statistical analysis 140 
Data were double entered and validated using EpiData version 3.1 (The EpiData Association, 141 
Odense Denmark). Data were analyzed using STATA 13.1 (StataCorp, College Station, TX, 142 
USA) with a complex survey design approach in which all observations were weighted for 143 
sampling strategy, non-response, and availability of interview data and sputum results. Survey 144 
weights were re-scaled to the initial enrolled population. The details of weighting are described 145 
in the Box.   146 
We compared demographic and clinical characteristics of cases and controls in an univariable 147 
analysis. We conducted multivariable logistic regression analysis to assess the independent 148 
effects of each factor associated with TB after adjusting for potential confounding effects of 149 
other variables. The multivariable regression model included variables with a P-value < 0.2 in 150 
univariable analysis. The population attributable fraction (PAF) of diabetes and HIV as a-priori 151 
identified ‘modifiable’ factors associated with TB was estimated using the “punaf” command. 152 
This method computes the ratio of the log of two scenario means for the outcome of interest, 153 
being the data as is, and data in which an exploratory variable of interest is set for all to be 154 
absent. This estimate is the population unattributable fraction, from which PAF is calculated. The 155 
methodology is able to handle multivariable models and data obtained from a complex survey 156 
design.8 The level of significance was set at P ≤ 0.05. 157 
Ethics 158 
The National Medical Research Coordinating Committee, Zanzibar Medical Research and Ethics 159 
Committee, and the Ethics Advisory Group of the International Union Against Tuberculosis and 160 
Lung Disease, Paris, France approved the study. All the participants provided written informed 161 
consent to participate in the study. 162 




In the prevalence survey, 50447 individuals aged ≥15 years were screened for TB. Of these, 165 
7163 participants (6302 presumptive TB patients and 861 non-presumptive TB) were requested 166 
to provide sputum specimens and be interviewed. Information on sputum results and factors 167 
associated with TB was present for 6073(85%) participants. Of these, 159 individuals were 168 
bacteriologically confirmed to have pulmonary TB (cases). Of the 159 bacteriologically 169 
confirmed cases, 22 were culture positive smear positive, 69 were culture positive smear 170 
negative, and 68 were culture negative smear positive. Furthermore, 66 cases were 171 
asymptomatic. Of the 5914 participants without study-defined bacteriologically confirmed TB, 172 
71 were either on TB treatment, or information regarding their current TB treatment status was 173 
missing, and the remaining 5843 individuals were  considered ‘controls’ (Figure 1). After 174 
applying survey weights, we had 152 cases and 5850 controls for analysis.  175 
Participants’ socio-demographic characteristics are shown in table 1. In univariable analysis, the 176 
chance of bacteriologically confirmed TB was higher among persons aged 25-34 years and 55-64 177 
years compared to those aged 15-24 years, and among men compared to women. Residents of 178 
Zanzibar were less likely to have TB compared to mainland semi-urban residents.  179 
Table 2 shows clinical characteristics of participants. On univariable analysis, those with 180 
previous TB were more likely to have TB compared to those who had no previous history, as 181 
were those with low BMI compared to those with normal BMI.  182 
Multivariable analysis of selected factors associated with TB is shown in table 3. The results 183 
remained similar to the univariable analysis. Place of residence was omitted from the 184 
multivariable analysis given no cases in the Zanzibar stratum. 185 
Population attributable fraction was calculated for diabetes and HIV. For diabetes it was found to 186 
be 2% and for HIV it was 3% (Figure 2). Due to lack of association, we did not assess PAF for 187 
alcohol use and smoking. 188 




This is the first study examining factors associated with prevalent TB on a national scale in 191 
Tanzania. We found more bacteriologically confirmed TB among persons of older age, among 192 
men, and among persons with low BMI. Surprisingly, we did not find statistically significant 193 
association with education, socio-economic position, history of previous TB, smoking, alcohol 194 
drinking, diabetes mellitus or HIV. The population impact of HIV and diabetes on prevalent TB 195 
was rather small. With prevalent TB being the pool of future transmission, these findings should 196 
result in a re-assessment of NTLP priority activities. 197 
Age was observed to be associated with TB disease, as demonstrated in other studies,9-11 with a 198 
high likelihood of having TB disease observed amongst older individuals (55 to 64 years). This 199 
correlates with the results of the prevalence survey which showed bacteriologically confirmed 200 
TB prevalence per 100,000 adult population in the respective age groups was 42, 303, 323, 260, 201 
673, 709.2 This is in contrast to the TB programme notification data where the notification rates 202 
among elderly people are less as compared to younger age groups,12, 13 thus indicating that older 203 
age groups are under-diagnosed in the programme. Data from another sub-study done on the 204 
same survey have shown that there was no difference in care seeking behavior between the older 205 
and the younger individuals with tuberculosis-associated symptoms.14 Therefore the low number 206 
of notified cases in the older age group is likely a consequence of low level of suspicion by 207 
health staff when dealing with elderly people. NTLP should train the health care workers to have 208 
a higher index of suspicion when screening elderly patients when they visit health care facilities. 209 
Moreover, NTLP should set up a screening programme for elderly people as a strategy to 210 
improve case finding. NTLP could train community health workers to screen elderly people in 211 
the community for TB symptoms (e.g., cough of >2 weeks' duration), and to refer those who will 212 
be found to have symptoms to a nearby health facility for TB testing and further management. 213 
However, it remains to be seen what an appropriate screening algorithm is in the elderly 214 
population. 215 
 216 
The increased risk of TB in men is well known and has been attributed to multiple factors. Some 217 
have suggested biological factors15 while others attribute to social behaviors of men which 218 
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increases their chance of exposure to TB.15, 16 The higher risk among men is reflected in the TB 219 
notification in Tanzania where 65% of reported cases in 2012 were men.12 220 
 221 
A person who had TB in the past (treated or not) has a higher risk of TB than a person who never 222 
had TB.17 In our study we see a point estimate indicating an association of TB with a past history 223 
of TB, but only statistically significant in the univariable analysis and not in multivariable 224 
analysis, probably due to few numbers of events. This group could be targeted for increased case 225 
detection. One possible approach could be to follow-up the successfully treated TB patients for a 226 
period of two years after treatment, to detect recurrent tuberculosis at the earliest and start 227 
appropriate treatment. It is suggested that the risk of recurrence in two years is about 4% and that 228 
about 90% of the relapses occur within two years of treatment completion.17 229 
 230 
Malnutrition  causes impairment of immune response.18 Several studies have shown low BMI to 231 
be associated with TB.19,20 In our study those with low BMI were 70% more likely to have TB 232 
compared to those with normal BMI. But these results should be interpreted with care as low 233 
BMI is also fairly consistently a result of TB, and our findings would then be the result of 234 
reverse causality.20  235 
 236 
Diabetes is known to adversely affect body immunity by impairing the innate and adaptive 237 
immune responses, thereby accelerating the proliferation of TB.18 Several studies have shown 238 
diabetes to be associated with TB,18, 21 but the association was not statistically significant in this 239 
study. Since the ascertainment of diabetes in our study was done by self-reporting, it is possible 240 
that people with undetected diabetes were misclassified22, 23 with consequent underestimation of 241 
the association.23 However, given the evidence from other studies and the increasing burden of 242 
diabetes in Tanzania,24 this is an important target group for TB screening.25 WHO and The 243 
Union have developed a collaborative framework for care and control of tuberculosis and 244 
diabetes. One of the recommendations in the framework is to screen all diabetes patients for 245 
TB.25 In Tanzania, diabetes clinics have been set-up as separated units within the health 246 
system.26, 27 These diabetes clinics provide a platform in which NTLP can use as entry points for 247 
active TB case finding. A study which was done in Mwanza, Tanzania, revealed that screening 248 
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of TB at diabetes clinics is possible and the point prevalence of tuberculosis among adults with 249 
diabetes was 7-fold higher than that reported in the general population.28  250 
 251 
While several studies have shown HIV as an independent risk factor for TB, we did not find a 252 
statistically significant association in our study.10, 18, 29 This may be due to several factors. First, 253 
we had small number of cases and hence underpowered to detect an association. Second, we 254 
used prevalent TB cases (which are by definition survivors), so it is possible that some of the 255 
HIV cases with TB might have died and are not included in the study. Third, declining HIV 256 
burden and increasing coverage of anti-retroviral therapy (ART) in Tanzania might be 257 
influencing this analysis. A factor strongly associated with an outcome on an individual level 258 
(like HIV and TB) does not have to have much population impact, if the exposure (e.g. HIV) is 259 
not common in the population at large. Declining HIV prevalence in the general population 260 
makes population impact low even though HIV is strongly associated with TB. Availability of 261 
ART, especially for those who start the treatment early, prevents HIV patients to develop 262 
opportunistic infections such as TB. 30-33 Studies in 1990s showed that about 30% of incident 263 
tuberculosis cases were attributable to HIV.5, 34 In our study PAF of prevalent tuberculosis for 264 
HIV was 3%. 265 
 266 
A strength of this study was that it was part of a large nationally representative, community-267 
based survey with strong internal and external monitoring of field activities. Also, the effect of 268 
non-response and missing data were mitigated by detailed weighting of these events in the 269 
analysis and the use of appropriate survey techniques for estimation. Having a sample of controls 270 
chosen from the general population, rather than just from the patients with presumptive TB 271 
during screening, is  a novel approach and gave the opportunity to assess effects on population 272 
level. The careful selection of controls resulted in an unbiased study population representative 273 
for the general population. 274 
The study had several limitations. As described before, we were underpowered to detect many 275 
associations, given the low number of TB cases detected in the survey. Since we used prevalent 276 
cases found with both exposure and outcome measurement done at the same point, it is 277 
impossible to establish temporality of association. Also, a prevalence study surveys only 278 
survivors and associations found in the study are a function of both risk of and survival after the 279 
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event. Another limitation relates to self-reported nature of alcohol drinking and smoking data. 280 
The data collectors were part of NTLP, known to disapprove alcohol drinking and smoking, and 281 
might therefore have caused the respondents to provide socially desirable responses. We think 282 
this might have led to under-reporting of the prevalence of smoking and drinking, and an 283 
underestimate of the effect of these two factors on TB. Furthermore, data collected concerning 284 
smoking and alcohol use could not be broken down in levels of smoking and alcohol use and this 285 
might have also affected our analysis. We lacked information on factors associated with TB and 286 
smear results for 15% of participants, who might be different from those whom we had their 287 
information, and this could have affected our estimates. We could not include prisons, refugee 288 
camps, mines, and other institutionalised populations in the study, who are known to have higher 289 
risk of having TB compared to the general population.35, 36 Also children under the age of 15 290 
years were not included in the prevalence survey and this might have influenced our results since 291 
factors associated with TB in children might be different from those for TB in adult. 292 
CONCLUSION 293 
In conclusion, being from older age group (55 to 64 years), being male, and having low BMI 294 
were associated with bacteriologically confirmed TB. The associations with HIV and diabetes 295 
were not statistically significant. NTLP should consider targeted screening activities in these 296 
groups who are more likely to have TB to reach ‘missed’ cases and eliminate TB. On a 297 
population level, classic risk factors for TB have no major effect on prevalent TB from which 298 
future transmission can derive.  299 
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Table 1. Socio-demographic characteristics of tuberculosis (TB) cases and controls in a 420 





Crude OR  
(95% CI) 
P value 
Total 152 (100) 5850 (100)   
Mean age in years (SD) 39 (17)  38 (18)   
Age in years     
 15-24 24 (16) 1788 (31) 1  
 25-34 54 (36) 1228 (21) 3.3 (1.4-7.6) 0.006 
 35-44 30 (20) 1030 (18) 2.2 (1.0-4.8) 0.051 
 45-54 12 (8) 643 (11) 1.5 (0.6-3.6) 0.409 
 55-64 18 (12) 612 (11) 2.2 (1.0-4.7) 0.040 
 65 and older 13 (9) 548 (9) 1.8 (0.8-4.3) 0.167 
 Not recorded 0 (0) 1 (0)   
Sex     
 Female 66 (43) 3308 (57) 1  
 Male 86 (57) 2542 (44) 1.7 (1.2-2.5) 0.008 
Place of residence (strata)     
 Semi-urban 33 (21) 1352 (23) 1  
 Zanzibar 0 (0) 165 (3) 0.1 (0.0-0.6) 0.014 
 Urban 25 (17) 843 (14) 1.2 (0.6-2.6) 0.557 
 Rural 94 (62) 3490 (60) 1.1 (0.6-2.0) 0.691 
Education     
 Higher education 2 (1) 62 (1) 1  
 Secondary 17 (11) 860 (15) 0.8 (0.1-6.2) 0.826 
 Primary 85 (56) 3402 (58) 1.0 (0.1-8.7) 0.989 
 None 48 (32) 1518 (26) 1.3 (0.2-10.9) 0.808 
 Not recorded 0 (0) 8 (0)   
Marital status     
 Never married 44 (29) 1502 (26) 1  
 Married/cohabiting 82 (54) 3415 (58) 0.8 (0.5-1.5) 0.487 
 Separated/widowed 25 (17) 921 (16) 0.9 (0.5-1.7) 0.813 
 Not recorded 0 (0.0) 12 (0)   
Socio-economic position     
 High 38 (25) 1742 (30) 1  
 Medium 53 (35) 2014 (34) 1.2 (0.6-2.3) 0.563 
 Low 61 (40) 2094 (36) 1.3 (0.8-2.4) 0.320 
 422 
OR = Odds Ratio, CI = Confidence Interval, TB = tuberculosis, SD = Standard Deviation 423 
Percentages have been rounded off to zero decimals and Odds ratios have been rounded off to 424 
one decimal point 425 
Information on the socio-economic position of the participants was collected through an assets-426 
score 427 
  428 
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Table 2.  Behavioural and clinical characteristics of tuberculosis (TB) cases and controls in 429 








Total 149 (100) 5924 (100)   
History of previous TB     
 No 128 (84) 5414 (93) 1  
 Yes 24 (16) 417 (7) 2.4 (1.2-4.7) 0.012 
 Not recorded 0 19 (0)   
Body Mass Index  (kg/m2)     
 <18.5 47 (31) 1177 (20) 1.7 (1.1-2.8) 0.030 
 18.5-24.9 84 (55) 3590 (61) 1  
 25-29.9 15 (10) 765 (13) 0.9 (0.3-2.1) 0.719 
 ≥30 4 (2) 269 (5) 0.6 (0.2-1.5) 0.254 
 Not recorded 3 (2) 49 (1)   
Smoking     
 Never smoker 125 (82) 4814 (82) 1  
 Ever smoker 27 (18) 1026 (18) 1.0 (0.6-1.7) 0.946 
 Not recorded 0 11 (0)   
Alcohol use     
 Never used 103 (68) 3989 (68) 1  
 Ever used 49 (32) 1852 (32) 1.0 (0.7-1.5) 0.894 
 Not recorded 0 10 (0)   
Diabetes     
 No 146 (96) 5794 (99) 1  
 Yes 4 (2) 45 (1) 3.1 (0.6-16.4) 0.186 
 Not recorded 3 (2) 12 (0)   
HIV Status     
 Negative 139 (92) 5549 (95) 1  
 Positive 12 (8) 301 (5) 1.6 (0.9-3.1) 0.128 
 431 
OR = Odds Ratio, CI = Confidence Interval, TB = tuberculosis  432 
Percentages have been rounded off to zero decimals and Odds ratios have been rounded off to 433 
one decimal point 434 
Information on the socio-economic position of the participants was collected through an assets-435 
score 436 
  437 
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Table 3. Adjusted Odds ratios of factors associated with tuberculosis in a national 438 
tuberculosis prevalence survey in Tanzania, 2012 439 
Characteristic Adjusted OR* P value 
Age (years)   
 15-24 1  
 25-34 3.7 (1.5-8.8) 0.004 
 35-44 2.3 (1.0-5.4) 0.053 
 45-54 1.6 (0.6-4.2) 0.380 
 55-64 2.5 (1.1-5.5) 0.028 
 65 and older 1.9 (0.8-4.6) 0.167 
Sex   
 Female 1  
 Male 1.6 (1.1-2.3) 0.024 
History of previous TB   
 No 1  
 Yes 1.9 (0.9-3.9) 0.087 
Body Mass Index  (kg/m2)   
 <18.5 1.7 (1.1-2.8) 0.028 
 18.5-24.9 1  
 25-29.9 0.9 (0.3-2.2) 0.725 
 ≥30 0.6 (0.2-1.7) 0.307 
Diabetes   
 No 1  
 Yes 3.4 (0.8-14.2) 0.097 
HIV Status   
 Negative 1  
 Positive 1.5 (0.7-2.9) 0.281 
 440 
OR = Odds Ratio, CI = Confidence Interval, TB = tuberculosis 441 
Odds ratios have been rounded off to one decimal point 442 
*Adjusted for age, sex, history of previous TB, Body Mass Index, diabetes, and HIV 443 
 444 
                                              

































TB = Tuberculosis 
Figure: Flowchart of study participants of a case control study nested in national prevalence TB survey, 
Tanzania, 2011-12 
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40 - On TB treatment 
31 - No information 
 
CL = confidence level 
Figure 2. Population Attributable Fraction for diabetes and HIV 
  
